GC
ALDR

Guggenheim Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Guggenheim Capital’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,973
Closed -$245K – 2875
2017
Q3 		$245K Sell
19,973
-89,583
-82% -$934K ﹤0.01% 2581
2017
Q2 		$1.25M Buy
109,556
+14,831
+16% +$274K ﹤0.01% 1939
2017
Q1 		$1.97M Buy
94,725
+4,745
+5% +$105K 0.01% 1674
2016
Q4 		$1.87M Buy
89,980
+7,472
+9% +$194K 0.01% 1739
2016
Q3 		$2.7M Sell
82,508
-8,210
-9% -$250K 0.01% 1412
2016
Q2 		$2.27M Sell
90,718
-19,253
-18% -$521K 0.01% 1487
2016
Q1 		$2.69M Buy
109,971
+52,784
+92% +$1.22M 0.01% 1365
2015
Q4 		$1.89M Buy
57,187
+6,028
+12% +$204K 0.01% 1655
2015
Q3 		$1.68M Buy
+51,159
New +$2.17M 0.01% 1727

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return